83 related articles for article (PubMed ID: 3954151)
1. Peripheral vascular disease: flow studies and clinical results after isovolemic hemodilution--case reports.
Caputi CA; De Carolis G
Angiology; 1986 Feb; 37(2):124-7. PubMed ID: 3954151
[TBL] [Abstract][Full Text] [Related]
2. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
[TBL] [Abstract][Full Text] [Related]
3. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
[TBL] [Abstract][Full Text] [Related]
4. Normovolemic hemodilution in peripheral arterial disease.
Rieger H; Köhler M; Schoop W; Schmid-Schönbein H
Ann Clin Res; 1981; 13 Suppl 33():78-83. PubMed ID: 7342848
[TBL] [Abstract][Full Text] [Related]
5. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
Weidinger P; Bilek M; Tekusch A
Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
[No Abstract] [Full Text] [Related]
6. Isovolemic hemodilution: a therapeutical intervention for improving microcirculation.
Rudofsky G
Int Angiol; 1986; 5(3):151-4. PubMed ID: 3559316
[TBL] [Abstract][Full Text] [Related]
7. [Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
Pöhlmann G; Braumann A; Grohmann G
Vasa Suppl; 1991; 32():342-4. PubMed ID: 1722914
[No Abstract] [Full Text] [Related]
8. [Dynamics of regional blood circulation in normovolemic hemodilution in patients with arterial occlusive diseases].
Kuznetsov NA; Bogdanov AE
Vestn Khir Im I I Grek; 1987 Sep; 139(9):19-24. PubMed ID: 3441964
[TBL] [Abstract][Full Text] [Related]
9. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
[TBL] [Abstract][Full Text] [Related]
10. Effects of isovolemic hemodilution on hemodynamics, cerebral perfusion, and cerebral vascular reactivity.
Tu YK; Liu HM
Stroke; 1996 Mar; 27(3):441-5. PubMed ID: 8610310
[TBL] [Abstract][Full Text] [Related]
11. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
[TBL] [Abstract][Full Text] [Related]
12. Use of isovolemic hemodilution in the management of arterial ischemia in patients with polycythemia.
Shah DM; Buchbinder D; Balko A; Karmody AM; Leather RP
Am J Surg; 1981 Aug; 142(2):233-5. PubMed ID: 7258533
[TBL] [Abstract][Full Text] [Related]
13. [Rheologic effects of normovolemic hemodilution].
Kuznetsov NA; Aleksandrova NP; Bogdanov AE; Rogulenko RV
Anesteziol Reanimatol; 1990; (2):18-22. PubMed ID: 1698041
[TBL] [Abstract][Full Text] [Related]
14. [Effect of stepwise hypervolemic versus isovolemic hemodilution in patients with intermittent claudication on muscle oxygen pressure during exercise].
Höffkes HG; Saeger-Lorenz K; Ehrly AM
Vasa; 1991; 20(2):109-18. PubMed ID: 1877329
[TBL] [Abstract][Full Text] [Related]
15. Isovolemic hemodilution in experimental focal cerebral ischemia. Part 1: Effects on hemodynamics, hemorheology, and intracranial pressure.
Tu YK; Heros RC; Candia G; Hyodo A; Lagree K; Callahan R; Zervas NT; Karacostas D
J Neurosurg; 1988 Jul; 69(1):72-81. PubMed ID: 3379478
[TBL] [Abstract][Full Text] [Related]
16. Isovolemic hemodilution as a functional therapy of decompensated arteriosclerotic stenoses of the femoral, cerebral and ophthalmic artery.
Schmid-Schönbein H; Rieger H
Ric Clin Lab; 1983; 13 Suppl 3():29-52. PubMed ID: 6673004
[TBL] [Abstract][Full Text] [Related]
17. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():45-7. PubMed ID: 1719731
[TBL] [Abstract][Full Text] [Related]
18. [MR-Imaging of lower leg muscle perfusion].
Leppek R; Hoos O; Sattler A; Kohle S; Azzam S; Al Haffar I; Keil B; Ricken P; Klose KJ; Alfke H
Herz; 2004 Feb; 29(1):32-46. PubMed ID: 14968340
[TBL] [Abstract][Full Text] [Related]
19. Blood flow properties and walking performance in chronic arterial occlusive disease.
Angelkort B; Spürk P; Habbaba A; Mähder M
Angiology; 1985 May; 36(5):285-92. PubMed ID: 3896044
[TBL] [Abstract][Full Text] [Related]
20. Effect of hemodilution on resting flow and reactive hyperemia in lower limbs.
Rudofsky G; Meyer P; Strohmenger HU
Bibl Haematol; 1981; (47):157-64. PubMed ID: 7337658
[No Abstract] [Full Text] [Related]
[Next] [New Search]